Multi-omics Model Predicts Efficacy of Preoperative Neoadjuvant Chemoradiotherapy Combined PD-1 Antibody Therapy for Locally Advanced Rectal Cancer
Clinical trial NCT05368051 · UNKNOWN
Trial details
- NCT number
- NCT05368051
- Sponsor
- Beijing Friendship Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-10-01
- Primary completion
- 2022-10-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.